We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Norvartis Splits Drug Business into Pharma, Oncology Divisons

News   May 19, 2016

 
Norvartis Splits Drug Business into Pharma, Oncology Divisons
 
 
 

RELATED ARTICLES

The Dangers Lurking Behind Certain Biologics

News

The surprising role of an immune cell that explains some of biologic drugs' side effects could lead to better treatments for persistent infections and cancer.

READ MORE

A New Toolkit Can Identify Microbial Communities and Their Functions

News

Study reports a new method of analyzing the codes found in RNA that can delineate human microbial communities and reveal how they operate.

READ MORE

The Right Mouse Is Key for Huntington's Drug Development

News

Scientists evaluated mouse models used for developing new treatments for mood disorders associated with Huntington's disease and recommend which are most relevant and have greater potential for success.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE